About US
Contact us
-
Novartis, Sanofi unveil data backing their rival MS pillsNovartis is touting a new data analysis suggesting that early treatment with its multiple sclerosis drugGilenyacan ward off relapses--and even prevent the loss of brain volume that often plaguesMSpati2012/10/15
-
Pfizer fleshes out Zoetis executive teamPfizer ($PFE) added to its lineup atZoetis, the animal health unit preparing for a spinoff. The drugmaker tapped 9 executive vice presidents to back up previously appointed CEO Juan Ramon Alaix. Amon2012/10/15
-
Report spies opportunity for ankylosing spondylitis drug developmentBiopharmaceutical companies have a major opportunity in the form of drug development for ankylosing spondylitis (AS), a report suggests.The chronic inflammatory disease has few treatment options, wi2012/10/12
-
Dedicated budgets for medical publication teams 'linked to higher output'In-house medical publication teams that have dedicated budgets in place tend to produce a greater number of manuscripts and abstracts each year, a study has found. Cutting Edge Information surveyed2012/10/12
-
Excipient research wins PhD candidate prestigious awardA PhD candidate from the US has won a global fellowship award from US Pharmacopeial for work involving excipients.Ting Wang, from the University of Marylan at Baltimore's School of Pharmacy, was rec2012/10/11
-
New excipients on show at CPhl Woldwide in MadridThe CPhl Worldwide event is one of the most important events in the calendar for pharma manufacturers, buyers and service suppliers and is expected to attract nearly 30,000 attendees from 133 countr2012/10/11
-
Successful inspection by FDA of Penn Pharma’s development and production facilityPenn Pharma announced today that its Tredegar, South Wales facility has successfully completed a routine FDA inspection. The inspection which covered compliance with cGMP (current Good Manufacturing2012/10/10
-
Future of Pharmaceutical R&D Requires Innovative Dosage Formulations, Industry Survey ShowsMORRISTOWN, N.J. and BORNEM, BELGIUM, October 9, 2012 – A survey of 500 pharmaceutical industry influencers reveals that four out of five surveyed (82%) believe innovative dosage form technologies are2012/10/10
-
Dow Chemical Company partners with Bend to develop new excipientsThe Dow Chemical Company has partnered with Bend Research to develop new excipients and drug-solubility solutions.Bend Research, which specialises in the development and manufacturing of drug formulat2012/10/9
-
BASF shows off its portfolio of excipientsBASF will feature a wide range of its pharmaceutical ingredients at an event in the US later this month, including its excipients.The company will be presenting its portfolio and accompanying services2012/10/9